Procedural Sedation and Analgesia: Safer and Smarter

Dr Neeraj Manikath , claude.ai

Abstract

Procedural sedation and analgesia (PSA) has evolved from an art practiced by intuition to a science underpinned by pharmacological precision and safety protocols. This review examines contemporary best practices in PSA, with particular emphasis on ketamine as the workhorse agent, systematic management of adverse events including laryngospasm and emergence phenomena, and nuanced approaches to special populations. Drawing on current evidence and decades of clinical experience, we present practical pearls that transform good sedation practice into exceptional patient care.

Introduction

Procedural sedation and analgesia represents one of the most frequently performed interventions in acute care settings, yet it remains fraught with potential complications when performed without systematic rigor. The modern intensivist must balance the competing demands of patient comfort, procedural success, hemodynamic stability, and airway safety—all while maintaining vigilance for rare but catastrophic complications.

The evolution of PSA has been marked by three paradigm shifts: first, the recognition that fasting guidelines from the operating room need not apply uniformly to emergency settings; second, the acceptance of dissociative sedation as distinct from traditional sedation-analgesia continua; and third, the understanding that adverse events are often preventable through anticipation rather than merely manageable through reaction.

Ketamine: The Workhorse Drug for PSA

Pharmacological Profile

Ketamine, a phencyclidine derivative, induces a unique state termed "dissociative sedation" characterized by functional and electrophysiological dissociation between the thalamus and limbic system. Unlike traditional sedative-hypnotics that depress the central nervous system along a continuum, ketamine produces catalepsy, amnesia, and profound analgesia while preserving protective airway reflexes and cardiorespiratory stability.

The pharmacokinetics of ketamine are particularly favorable for PSA. Following intravenous administration, onset occurs within 30-60 seconds, with peak effect at 1-2 minutes and duration of 10-20 minutes. Redistribution from the CNS to peripheral tissues explains its relatively brief duration of action despite a longer elimination half-life of 2-3 hours. Intramuscular administration, while slower (onset 3-5 minutes, peak 5-10 minutes), provides reliable absorption when intravenous access is challenging—a particularly valuable attribute in the uncooperative pediatric or agitated patient.

Clinical Advantages: Why Ketamine Dominates PSA

Cardiovascular Stability: Unlike propofol or benzodiazepines, ketamine stimulates the sympathetic nervous system, resulting in maintained or increased blood pressure and heart rate. This sympathomimetic effect proves invaluable in the hemodynamically unstable patient, though caution is warranted in patients with coronary disease where increased myocardial oxygen demand may precipitate ischemia.

Respiratory Preservation: Perhaps ketamine's most celebrated attribute is preservation of respiratory drive and protective airway reflexes. While not absolute—respiratory depression can occur, particularly with rapid bolus administration or co-administration of other sedatives—the incidence is substantially lower than with traditional agents. This characteristic makes ketamine particularly attractive for PSA in locations where immediate airway rescue may be challenging.

Profound Analgesia: Ketamine's NMDA receptor antagonism provides potent analgesia that persists beyond the dissociative effects. Sub-dissociative doses (0.1-0.3 mg/kg IV) can serve as effective adjuncts to opioid analgesia, potentially reducing opioid requirements and associated side effects.

Dosing Strategies: The Devil in the Details

Standard IV Dosing: For adults, 1-2 mg/kg IV administered over 30-60 seconds typically achieves adequate dissociation. The critical error lies in inadequate initial dosing, leading to an inadequate plane of sedation, patient distress, and the need for supplemental doses that prolong recovery. Underdosing is more problematic than modest overdosing.

Intramuscular Route: When IV access is unavailable or impractical, 4-5 mg/kg IM provides reliable dissociation. The IM route is particularly valuable in the combative patient requiring emergent procedures or in pediatric populations where IV placement may prove the most traumatic aspect of care.

Pediatric Considerations: Children typically require the higher end of dosing ranges (1.5-2 mg/kg IV, 4-5 mg/kg IM) due to increased volume of distribution and faster clearance. The mistake of adult-dose extrapolation frequently results in inadequate sedation.

Supplemental Dosing: If initial dosing proves insufficient, supplemental doses of 0.5 mg/kg IV (one-quarter to one-half the initial dose) may be administered. However, supplemental dosing increases the risk of prolonged recovery and emergence reactions.

Pearl: The "Ketamine Drift"

Experienced practitioners recognize the phenomenon of "ketamine drift"—the patient who appears adequately dissociated initially but gradually becomes more responsive during prolonged procedures. Rather than immediately administering supplemental ketamine, consider whether the procedure can be completed expeditiously. If supplementation is necessary, smaller incremental doses (0.25-0.5 mg/kg) are preferable to repeated full induction doses.

Oyster: Ketamine is NOT Absolutely Airway-Protective

The most dangerous misconception about ketamine is that it absolutely preserves airway reflexes. While protective reflexes are generally maintained, laryngospasm, excessive salivation leading to airway obstruction, and apnea can occur. Every ketamine sedation must be approached with the same airway preparedness as any other deep sedation. The availability of bag-valve-mask ventilation, suction, and airway rescue equipment is non-negotiable.

Contraindications: Real and Theoretical

Absolute Contraindications (rare):

• Known hypersensitivity to ketamine
• Conditions where elevated intracranial pressure would be dangerous (though this remains controversial in modern literature)
• Age less than 3 months (limited safety data)

Relative Contraindications (require risk-benefit assessment):

• Uncontrolled hypertension or cardiovascular instability where sympathetic stimulation is undesirable
• Acute globe injury (though evidence for increased intraocular pressure is conflicting)
• Psychosis or severe psychiatric disturbance
• Thyroid dysfunction (particularly hyperthyroidism)

The historical contraindication of head injury has been largely abandoned, as emerging evidence suggests ketamine may not increase intracranial pressure in ventilated patients and may even have neuroprotective properties.

Managing Adverse Events: Laryngospasm and Emergence Reactions

Laryngospasm: Recognition and Management

Laryngospasm represents the most serious respiratory complication of ketamine sedation, occurring in approximately 0.4-1.4% of pediatric cases and less frequently in adults. It manifests as complete or partial closure of the vocal cords, resulting in high-pitched inspiratory stridor or complete airway obstruction.

Risk Factors:

• Age less than 5 years or greater than 13 years (bimodal distribution in pediatric population)
• Upper respiratory infection within 2 weeks (relative risk increases 2-5 fold)
• Reactive airway disease
• Stimulation of the oropharynx during inadequate depth of sedation
• Excessive salivation with pooling of secretions

Prevention Strategies:

1. Antisialagogue administration: Glycopyrrolate (0.005-0.01 mg/kg IV, maximum 0.2 mg) or atropine (0.01 mg/kg IV) administered 3-5 minutes before ketamine reduces salivation. While not universally practiced, antisialagogues are particularly valuable in young children, prolonged procedures, or when airway manipulation is anticipated.

2. Depth of sedation: Laryngospasm most commonly occurs during light planes of dissociation. Ensuring adequate initial dosing and avoiding premature stimulation are critical.

3. Gentle suctioning: When suctioning is necessary, use gentle technique and avoid posterior pharyngeal stimulation.

Management Algorithm:

1. Immediate recognition: High index of suspicion with any change in respiratory pattern
2. Positive pressure ventilation: Gentle bag-valve-mask with 100% oxygen, maintaining a tight seal
3. CPAP: Continuous positive airway pressure (10-15 cm H₂O) often breaks the spasm
4. Larson's maneuver: Firm pressure applied bilaterally at the "laryngospasm notch" (behind the lobule of the ear, between the mandible and mastoid process) combined with anterior jaw thrust
5. Pharmacological intervention: If not rapidly responsive, consider:
   • Propofol 0.5-1 mg/kg IV (deepens sedation, relaxes laryngeal musculature)
   • Succinylcholine 0.1-0.5 mg/kg IV (in extremis, requires advanced airway management capability)

Hack: The "Ketamine Cough"

Brief coughing immediately following ketamine administration, sometimes accompanied by transient oxygen desaturation, represents excessive salivation with microaspiration rather than true laryngospasm. This typically resolves spontaneously and does not require intervention beyond repositioning and gentle suctioning. Distinguishing this benign phenomenon from true laryngospasm prevents unnecessary escalation of intervention.

Emergence Reactions: Prevention and Management

Emergence reactions occur in 5-30% of adult patients, manifesting as agitation, dysphoria, vivid dreams, hallucinations, or delirium during recovery. Pediatric patients experience substantially lower rates (1-5%), likely due to developmental differences in dream interpretation and anxiety.

Risk Factors:

• Age greater than 16 years
• Female sex
• Baseline anxiety or psychiatric history
• Doses exceeding 2 mg/kg
• History of frequent dreaming or nightmares
• Stimulating recovery environment

Prevention Strategies:

1. Benzodiazepine co-administration: Midazolam 0.03-0.05 mg/kg IV (typically 1-2 mg in adults) administered either 3-5 minutes before ketamine or concurrently reduces emergence phenomena by 50-70%. The trade-off is prolonged recovery time and potential synergistic respiratory depression.

2. Environmental modification: Minimize auditory and visual stimulation during recovery. Dim lights, reduce noise, and limit unnecessary physical examination or conversation.

3. Patient selection and preparation: Frank discussion of potential dream-like experiences may reduce anxiety when they occur. Avoid ketamine in patients with severe anxiety about dissociative experiences.

Management of Established Reactions:

• Reassurance: Verbal orientation that the experience is temporary and expected
• Benzodiazepines: Midazolam 1-2 mg IV for severe agitation
• Time: Most reactions resolve within 15-30 minutes without intervention
• Physical restraint: Avoid unless necessary for patient safety, as it may intensify dysphoria

Pearl: Recovery Room Coaching

Instruct recovery room staff that patients emerging from ketamine sedation should be allowed to "wake up at their own pace" without aggressive stimulation. Premature attempts to orient or examine patients frequently trigger or intensify emergence reactions. A quiet, dimly lit space with minimal interaction until the patient spontaneously engages proves optimal.

Special Populations: Pediatric, Elderly, and High-Risk Patients

Pediatric PSA: Unique Considerations

The pediatric population represents both the ideal and the most challenging scenario for PSA. Children benefit dramatically from sedation that transforms potentially traumatic procedures into tolerable experiences, yet their smaller physiological reserves make adverse events potentially more consequential.

Developmental Differences:

• Infants (<6 months): Higher risk of apnea, less predictable drug response, limited ability to cooperate with monitoring
• Toddlers (1-3 years): Maximal anxiety with separation, potential for airway obstruction from large tongue and tonsillar tissue
• School-age (4-10 years): Generally optimal candidates for PSA, able to cooperate with monitoring
• Adolescents: Increased risk of emergence reactions, approaching adult dosing requirements

Fasting Considerations in Pediatrics: Traditional NPO guidelines (nothing by mouth for 6-8 hours) have been liberalized for emergency PSA. Current evidence suggests that the aspiration risk in emergency procedures is not meaningfully increased by recent food intake, while strict fasting may increase anxiety, dehydration, and hypoglycemia. Most emergency medicine and pediatric emergency medicine societies now accept that urgent procedures should not be delayed for fasting, though elective procedures may justify waiting when clinically reasonable.

Dosing Pearls:

• Weight-based calculations should use actual body weight, not ideal body weight
• Consider IM route early in the uncooperative child rather than traumatizing with prolonged IV attempts
• Intranasal ketamine (3-5 mg/kg) offers an alternative non-invasive route, though bioavailability is variable

Pediatric Hack: The "Pre-oxygenation Protocol"

In young children, establish baseline oxygen saturation and apply oxygen by blow-by or nasal cannula 2-3 minutes before ketamine administration. This pre-oxygenation provides an oxygen reservoir that extends the time to desaturation if apnea or laryngospasm occurs, buying critical seconds for intervention. Avoid frightening the child with a tight-fitting mask; passive oxygen delivery is sufficient.

Geriatric PSA: Respecting Reduced Reserve

The elderly patient presents challenges of polypharmacy, comorbid disease, and reduced physiological reserve. Age-related pharmacokinetic and pharmacodynamic changes mandate dosing adjustments and heightened vigilance.

Physiological Considerations:

• Decreased cardiac output prolongs circulation time, delaying drug effect
• Reduced lean body mass and total body water increase drug concentration
• Decreased hepatic metabolism and renal clearance prolong drug effect
• Impaired baroreceptor reflexes increase risk of hypotension
• Baseline cognitive impairment may be difficult to distinguish from sedation effects

Dosing Modifications: Reduce ketamine dosing by 30-50% in patients over 65 years, using 0.5-1 mg/kg IV for initial dosing. The adage "start low and go slow" applies universally to geriatric sedation. Titration to effect with smaller incremental doses (0.25 mg/kg) reduces the risk of oversedation.

Comorbidity Considerations:

• Cardiac disease: While ketamine's sympathomimetic effects generally support blood pressure, coronary disease patients may not tolerate increased myocardial oxygen demand. Consider alternative agents or very cautious dosing with nitrate availability.
• Cognitive impairment: Baseline dementia increases risk of delirium. Document baseline mental status carefully.
• Polypharmacy: Drug interactions, particularly with benzodiazepines, opioids, or antihypertensives, may be synergistic.

Pearl: The Geriatric Recovery Challenge

Elderly patients frequently require prolonged recovery periods despite receiving reduced dosing. Plan for extended post-procedure monitoring (60-90 minutes rather than the typical 30-45 minutes) and have low threshold for observation admission if recovery is incomplete. The pressure to expedite throughput should never compromise safe discharge.

High-Risk Patients: Obesity, OSA, and Critical Illness

Obese Patients: Obesity presents unique challenges for PSA, including difficult IV access, challenging bag-valve-mask ventilation if needed, higher aspiration risk, and baseline hypoxemia. Ketamine dosing should be based on total body weight rather than ideal body weight, as ketamine is lipophilic with a high volume of distribution. Position the obese patient in reverse Trendelenburg (head elevated 20-30 degrees) to optimize functional residual capacity and reduce aspiration risk.

Obstructive Sleep Apnea (OSA): Patients with diagnosed or suspected OSA (witnessed apnea, loud snoring, obesity, daytime somnolence) are at increased risk of airway obstruction during sedation. While ketamine's airway-preserving properties make it preferable to other agents, increased vigilance is mandatory. Consider:

• Pre-procedure continuous positive airway pressure (CPAP) for known OSA patients
• Aggressive jaw thrust and airway positioning during sedation
• Extended monitoring during recovery
• Lower threshold for consultation with anesthesia for alternative approaches

Critically Ill Patients: PSA in the critically ill intensive care patient requires modification of standard approaches:

• Hemodynamic instability: While ketamine supports blood pressure in most patients, the catecholamine-depleted patient in distributive shock may paradoxically experience hypotension due to ketamine's intrinsic myocardial depressant effects unmasked when sympathetic compensation is exhausted. Consider push-dose pressors availability.
• Elevated intracranial pressure: Modern evidence suggests ketamine may be acceptable, but consultation with neurosurgery and careful blood pressure management are prudent.
• Respiratory failure: Pre-procedure optimization of oxygenation and ventilation, consideration of non-invasive positive pressure ventilation during PSA, and immediate availability of advanced airway equipment are essential.

Hack: The "Ketamine Bridge"

In the critically ill patient requiring semi-urgent procedures (chest tube placement, cardioversion, orthopedic reduction), ketamine serves as an excellent "bridge" sedative when transitioning from ICU sedation. Rather than allowing propofol or dexmedetomidine infusions to wear off completely before the procedure, administer ketamine while baseline sedation is still present but lightened. This approach maintains comfort while exploiting ketamine's unique cardiovascular profile. Careful titration is essential to avoid excessive sedation depth.

Monitoring and Safety Systems

Regardless of agent or population, systematic monitoring forms the foundation of safe PSA. Standard monitoring includes:

• Continuous pulse oximetry
• Continuous capnography (particularly valuable for early detection of hypoventilation before oxygen desaturation)
• Intermittent blood pressure monitoring (every 3-5 minutes during procedure, every 5-10 minutes during recovery)
• Continuous electrocardiography in patients with cardiac disease
• Continuous visual observation by a dedicated provider

The concept of "procedural pause" borrowed from the operating room applies equally to PSA. Before administering sedation, verify: patient identity, procedure planned, informed consent obtained, fasting status documented, pre-procedure assessment completed, monitoring equipment functional, airway equipment immediately available, and recovery area prepared.

Conclusion

Procedural sedation and analgesia represents a high-stakes intervention where excellence depends upon systematic preparation, pharmacological precision, and anticipation of complications. Ketamine's unique pharmacological profile establishes it as the workhorse agent for PSA, but its use demands respect for potential adverse events and modification for special populations.

The competent intensivist approaches each PSA as a miniature anesthetic, with the same rigor and preparation afforded to operating room cases. The excellent intensivist recognizes that superior outcomes emerge not from managing complications expertly but from preventing them systematically through attention to detail, appropriate patient selection, optimal dosing, and vigilant monitoring.

As we advance PSA practice, the goal extends beyond procedural success to encompass patient experience, safety culture, and outcome optimization. In this framework, ketamine emerges not merely as a drug but as an enabler of compassionate, effective acute care.

Key Pearls Summary

1. Dosing confidence: Underdosing ketamine creates more problems than modest overdosing
2. Antisialagogues: Consider routinely in children and prolonged procedures
3. Environmental control: Recovery environment profoundly influences emergence reactions
4. Age-adjusted approach: Reduce dosing 30-50% in elderly, increase dosing in children
5. Capnography: Detects respiratory compromise earlier than pulse oximetry alone
6. Preparation: Equipment for airway rescue must be immediately available, not "nearby"
7. Recovery patience: Avoid premature stimulation during emergence
8. Risk stratification: OSA, obesity, and critical illness demand heightened vigilance

---

References (Selected Key Literature):

1. Green SM, Roback MG, Krauss B, et al. Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department. Ann Emerg Med. 2009;54(2):158-168.

2. Bhatt M, Johnson DW, Chan J, et al. Risk factors for adverse events in emergency department procedural sedation for children. JAMA Pediatr. 2017;171(10):957-964.

3. Godwin SA, Burton JH, Gerardo CJ, et al. Clinical policy: procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2014;63(2):247-258.

4. Messenger DW, Murray HE, Dungey PE, et al. Subdissociative-dose ketamine versus fentanyl for analgesia during propofol procedural sedation. Acad Emerg Med. 2008;15(10):877-886.

5. Roback MG, Carlson DW, Babl FE, et al. Update on pharmacological management of procedural sedation for children. Curr Opin Anaesthesiol. 2016;29(Suppl 1):S21-S35.

6. Andolfatto G, Abu-Laban RB, Zed PJ, et al. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia. Ann Emerg Med. 2012;59(6):504-512.

7. Scherzer D, Leder M, Tobias JD. Pro-con debate: etomidate or ketamine for rapid sequence intubation in pediatric patients. J Pediatr Pharmacol Ther. 2012;17(2):142-149.

8. Miner JR, Moore JC, Austad EJ, et al. Randomized, double-blinded, clinical trial of propofol, 1:1 propofol/ketamine, and 4:1 propofol/ketamine for deep procedural sedation in the emergency department. Ann Emerg Med. 2015;65(5):479-488.

---

Word count: Approximately 3,800 words

Author's Note: This review reflects contemporary evidence-based practice in PSA while acknowledging that protocols continue to evolve. Practitioners should adapt recommendations to their institutional guidelines, patient populations, and clinical expertise.

 

The Code Stroke Overhaul: From Lytics to Thrombectomy

A Practical Guide for the Modern Critical Care Physician

Dr Neeraj Manikath , claude.ai

---

Abstract

The landscape of acute ischemic stroke management has undergone a revolutionary transformation over the past decade. While intravenous thrombolysis once represented the pinnacle of acute stroke therapy, mechanical thrombectomy (MT) has emerged as the dominant intervention for large vessel occlusions (LVO), fundamentally reshaping stroke systems of care. This review examines contemporary evidence-based approaches to acute stroke management, focusing on expanded time windows through advanced imaging selection, direct-to-angiography suite pathways, and the nuanced post-thrombectomy care that bridges interventional radiology and critical care medicine.

---

Introduction

The 2015 publication of landmark trials (MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, and REVASCAT) established mechanical thrombectomy as standard of care for proximal large vessel occlusions within 6 hours of symptom onset.^1-5 Subsequent paradigm shifts emerged with DAWN (2018) and DEFUSE-3 (2018), which extended the therapeutic window to 24 hours using perfusion imaging selection criteria.^6,7 Today's stroke systems must integrate rapid triage, advanced neuroimaging protocols, and streamlined care pathways while navigating the complex post-intervention period.

The evolution from "time is brain" to "tissue is brain" represents more than semantic distinction—it embodies a fundamental reconceptualization of acute stroke as a heterogeneous condition requiring individualized assessment rather than rigid temporal cutoffs.⁸

---

Expanding the Window: Imaging Selection for Late Arrivals

The Paradigm Shift: From Clock to Physiology

The traditional 4.5-hour window for IV thrombolysis and early 6-hour thrombectomy window were predicated on population-level averages that failed to account for collateral circulation variability and individual ischemic tolerance. Advanced imaging modalities now permit identification of patients with salvageable tissue far beyond these arbitrary temporal boundaries.

Perfusion Imaging: The Foundation

CT Perfusion (CTP) vs. MRI Perfusion:

Both modalities assess the ischemic penumbra—the hypoperfused but viable tissue surrounding the infarct core. CTP offers advantages in speed and availability, while MRI provides superior posterior fossa visualization and avoids radiation exposure.⁹

Key Parameters:

• Cerebral Blood Flow (CBF): <30% of contralateral hemisphere suggests core
• Mean Transit Time (MTT): Prolonged in both core and penumbra
• Time to Maximum (Tmax): >6 seconds defines critical hypoperfusion
• Mismatch Ratio: Tmax >6s volume / Core volume ≥1.8 (DEFUSE-3 criteria)⁷

Pearl: In DAWN trial criteria, clinical-core mismatch alone sufficed for patient selection (6-24 hours), demonstrating that significant disability with minimal infarction suggests robust penumbra even without perfusion imaging.⁶

DAWN and DEFUSE-3: The Evidence Base

DAWN Trial (DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes):

• Enrollment 6-24 hours from last known well
• Clinical-imaging mismatch: severe deficit (NIHSS ≥10) with small core (<21 mL if age ≥80 or NIHSS ≥20; <31 mL if age <80 and NIHSS 10-19; <51 mL if age <80 and NIHSS ≥20)
• Number needed to treat: 2.8 for functional independence
• Modified Rankin Score (mRS) 0-2: 49% vs. 13% (control)⁶

DEFUSE-3 Trial:

• Enrollment 6-16 hours from last known well
• Target mismatch ratio ≥1.8 with mismatch volume ≥15 mL
• Core volume <70 mL
• mRS 0-2: 45% vs. 17% (control)⁷

Oyster: Both trials excluded patients with extremely large cores (>70-100 mL), yet real-world registries suggest potential benefit even in some patients exceeding these thresholds, particularly with good collaterals. Clinical judgment remains paramount.¹⁰

Wake-Up Strokes: A Special Population

Approximately 25% of ischemic strokes occur during sleep. The "last known well" time technically extends to when the patient fell asleep, often exceeding traditional windows. WAKE-UP trial demonstrated efficacy of IV alteplase in patients with DWI-FLAIR mismatch (visible on DWI but not FLAIR, suggesting <4.5 hour equivalent age).¹¹

Practical Hack: For wake-up strokes presenting early, consider tandem IV thrombolysis + thrombectomy if imaging criteria met. The brief delay for IV therapy rarely impacts thrombectomy timing when given in parallel during preparation.

Collateral Assessment: The Unsung Hero

Robust leptomeningeal collaterals preserve penumbra and predict better outcomes. Multiple grading systems exist:

CT Angiography-Based:

• Miteff Score: Grade 0 (absent) to 3 (100% filling)
• Tan Score: Regional assessment of collateral extent
• Multiphase CTA: Superior temporal resolution showing delayed collateral filling¹²

Pearl: Multiphase CTA requires no additional contrast and significantly improves collateral assessment compared to single-phase imaging. Push for institutional protocols incorporating this technique.

Imaging Protocol Optimization

Recommended Acute Stroke Imaging Battery:

1. Non-contrast CT: Exclude hemorrhage, assess early ischemic changes (ASPECTS score)
2. CTA head and neck: Identify LVO, assess collaterals, evaluate for tandem lesions
3. CTP: If presenting >6 hours or wake-up stroke; acquire during CTA with same contrast bolus
4. Alternative: MRI with DWI/FLAIR/MRA/PWI if available rapidly

Time Target: Door-to-imaging completion <20 minutes; door-to-groin puncture <90 minutes for direct transfers.¹³

Hack: Pre-hospital notification should trigger automatic "stroke imaging protocol" activation, eliminating delays for individual test ordering. The entire suite completes in <10 minutes.

---

Direct to Angio Suite: Bypassing the ED for Eligible Patients

The Rationale: Every Minute Matters

Despite 24-hour windows for selected patients, earlier reperfusion consistently correlates with superior outcomes. Each 15-minute delay reduces probability of good outcome by 4%.¹⁴ Traditional workflows—ED triage, examination, imaging, interpretation, neurology consultation, neurointerventionalist activation—introduce unnecessary delays for patients clearly requiring thrombectomy.

Patient Selection for Direct Transfer

Ideal Candidates:

• Pre-hospital LAMS (Los Angeles Motor Scale) or RACE (Rapid Arterial Occlusion Evaluation) score suggesting LVO
• NIHSS ≥6 (sensitivity for LVO)
• Last known well <6 hours (or <24 hours with mobile stroke unit CT showing small core)
• No contraindications to angiography
• Presenting directly to thrombectomy-capable center

Exclusion Criteria:

• Hemodynamic instability requiring resuscitation
• Known or suspected intracerebral hemorrhage
• Seizure at onset (mimics)
• Rapid improvement to NIHSS <6

Pearl: The FAST-MAG trial demonstrated feasibility and safety of pre-hospital magnesium administration, validating the concept that EMS can initiate sophisticated stroke protocols. Similar infrastructure enables direct-to-angio decisions.¹⁵

Mobile Stroke Units: The Ultimate Bypass

MSU-equipped ambulances with onboard CT, point-of-care laboratory, and telemedicine-enabled neurologists represent the logical extreme of early intervention. The BEST-MSU trial demonstrated 1-hour earlier treatment times and improved 90-day outcomes.¹⁶

Oyster: MSU implementation requires substantial investment (~$1-2 million per unit plus operational costs). Cost-effectiveness depends on regional stroke volume, geography, and existing EMS transport times. Not universally applicable but transformative in high-volume urban centers.

Workflow Design: Orchestrating the Bypass

Pre-Hospital Phase:

1. EMS activation: Stroke screening tool (LAMS/RACE/CPSS)
2. Pre-notification: Direct to neurointerventionalist on-call
3. Mobile communication: Real-time vital signs, glucose, clinical status
4. Destination determination: Nearest thrombectomy center (not just stroke-ready)

In-Hospital Phase (Direct to Angio Suite Protocol):

1. Angio suite preparation: Begins during EMS transport
2. Streamlined consent: Often verbal initially; family contacted en route
3. Parallel processing:
   • IV access, labs drawn in angio suite
   • Simultaneous CT/CTA in neuroradiology (if immediately adjacent) OR
   • Cone-beam CT in angio suite (emerging technology)
4. IV alteplase: Administered in angio suite pre-procedure if eligible
5. Groin puncture goal: <30 minutes from hospital arrival

Hack: Create physical proximity. Institutions with CT scanners adjacent to or within the angio suite complex reduce door-to-puncture times by 20-30 minutes.¹⁷

Addressing the "What About IV tPA?" Question

Current Evidence:

• DIRECT-MT and SKIP trials (Asian populations) showed non-inferiority of thrombectomy alone vs. combined IV thrombolysis + thrombectomy for proximal LVO^18,19
• However, DIRECT-SAFE (more international) suggested potential benefit of combination therapy²⁰
• Meta-analyses show marginal benefit favoring combination, particularly for successful recanalization rates²¹

Practical Approach:

• If no delay: Administer IV alteplase en route to angio suite (door-to-needle <20 min)
• If delay anticipated: Proceed directly to thrombectomy; don't delay for IV therapy
• Tandem occlusions or distal targets: Consider IV therapy to treat emboli beyond thrombectomy reach

Pearl: Tenecteplase (0.25 mg/kg IV bolus) shows promise as alteplase alternative with easier administration and potentially superior recanalization for LVO. Multiple trials ongoing; some centers already adopting off-label.²²

Safety Concerns and Mitigations

Bypassing ED examination risks missing:

• Hemorrhagic stroke (mitigated by imaging)
• Stroke mimics (seizure, hypoglycemia, conversion disorder)
• Medical instability (MI, sepsis)

Mitigations:

1. Brief focused assessment by angio suite team (2 minutes)
2. Point-of-care glucose universally
3. Telemedicine neurologist can perform virtual NIHSS
4. Low threshold for ED re-routing if clinical uncertainty

Oyster: False-positive LVO rates range 15-30% with prehospital screening tools. Over-triage is acceptable—delays to true LVO patients from under-triage cause greater harm than unnecessary angio suite activations.²³

Institutional Implementation

Checklist for Direct-to-Angio Programs:

• ☐ 24/7 thrombectomy capability
• ☐ Neurointerventionalist buy-in and availability
• ☐ Pre-hospital provider training and protocols
• ☐ Integrated communication system (EMS-hospital)
• ☐ Anesthesia availability (general anesthesia for select cases)
• ☐ Nursing staff trained in acute angio suite stroke care
• ☐ Quality metrics and continuous feedback loop

---

Managing the Post-Thrombectomy Patient in the ED

While many thrombectomy patients transfer directly to neuro-ICU, ED management of immediate post-procedure complications and stabilization remains essential, particularly when ICU beds unavailable or for patients initially bypassing ED.

The First Hour: Critical Decision Points

Immediate Post-Procedure Assessment:

1. Neurological Status

   • Repeat NIHSS (compare to pre-procedure baseline)
   • Assess for hyperperfusion syndrome: severe headache, seizures, focal deficits worsening paradoxically
   • Pearl: Dramatic early improvement (NIHSS drop ≥8 points) predicts excellent outcomes but monitor for hemorrhagic transformation

2. Blood Pressure Management

   • Most critical intervention in post-thrombectomy care
   • Target: <140/90 mmHg for first 24 hours if recanalization successful (TICI 2b-3)
   • Target: <180/105 mmHg if recanalization failed
   • Rationale: Successful reperfusion restores pressure to damaged blood-brain barrier, increasing hemorrhage risk
   • Agents: IV nicardipine (preferred for titratable control), labetalol, clevidipine
   • Hack: Start nicardipine drip prophylactically if SBP >140 mmHg rather than waiting for escalation—preventing BP spikes is easier than treating them²⁴

3. Groin Access Site

   • Assess for hematoma, bleeding, distal pulses
   • Maintain bed rest per institutional protocol (2-6 hours typical)
   • Check activated clotting time if heparin used during procedure

Hemorrhagic Transformation: Recognition and Management

Risk Factors:

• Large infarct core (ASPECTS <6)
• Delayed reperfusion
• Poor collaterals
• Aggressive BP elevation post-procedure
• Concomitant IV thrombolysis
• Anticoagulation

Types:

• HI-1/HI-2 (Hemorrhagic Infarction): Petechial hemorrhage, usually asymptomatic
• PH-1 (Parenchymal Hematoma): <30% of infarct, minimal mass effect
• PH-2: >30% of infarct with significant mass effect—associated with poor outcomes²⁵

Surveillance Strategy:

• Routine post-thrombectomy imaging: 24-hour non-contrast CT for all patients
• Urgent imaging if: Neurological deterioration, new headache, declining consciousness, seizure

Management of Symptomatic ICH:

1. Reverse anticoagulation:
   • IV thrombolysis cases: Consider tranexamic acid 1g IV if <3 hours from tPA
   • Hold antiplatelet agents
   • Platelets if thrombocytopenic (<100K) or recent clopidogrel with clinical deterioration
2. Blood pressure: Liberalize targets to SBP 140-180 to maintain cerebral perfusion
3. ICP management: Elevate HOB 30°, osmotherapy if indicated
4. Neurosurgical consultation: Consider for cerebellar hematomas or space-occupying supratentorial hemorrhage

Oyster: Routine platelet transfusion for ICH after IV thrombolysis may worsen outcomes (PATCH trial)—reserve for active bleeding or coagulopathy.²⁶

Medical Complications: Proactive Management

1. Cerebral Edema

• Peaks 3-5 days post-stroke but early identification crucial
• Risk factors: Large MCA territory infarction (>50%), younger age, early ischemic changes
• Monitoring: Serial neurological exams q1-2h, threshold for repeat imaging
• Management:
  • Hyperosmolar therapy: Mannitol 0.25-1 g/kg or hypertonic saline (goal Na 145-155)
  • HOB elevation 30°
  • Avoid hyperthermia, hyperglycemia, hypoxia
  • Pearl: Decompressive hemicraniectomy reduces mortality in malignant MCA syndrome if performed <48 hours; discuss early with neurosurgery for appropriate candidates²⁷

2. Aspiration Pneumonia

• 20-30% of acute stroke patients
• Prevention is key:
  • NPO until formal swallow evaluation
  • HOB ≥30° at all times
  • Meticulous oral care
• Hack: Bedside water swallow test (3 oz) has 94% sensitivity for aspiration risk; safe for early screening in alert patients²⁸

3. Seizures

• Occur in 5-10% post-stroke; higher risk with hemorrhagic transformation
• Management: Levetiracetam 500-1000 mg IV load preferred (no hepatic metabolism, fewer interactions than phenytoin)
• No role for prophylactic anticonvulsants unless specific indications

4. Hyperglycemia

• Independently predicts poor outcomes and hemorrhagic transformation
• Target: 140-180 mg/dL
• Method: IV insulin infusion for persistent hyperglycemia >180; avoid hypoglycemia (<70 mg/dL) equally harmful²⁹

Antithrombotic Management: The 24-Hour Dilemma

Post-Thrombectomy Antiplatelet Therapy:

Standard Approach (No IV tPA):

• If no hemorrhagic transformation on 24-hour CT: Start aspirin 325 mg daily
• Consider dual antiplatelet therapy (DAPT): Aspirin + clopidogrel 75 mg for 21-90 days if minor stroke (NIHSS <3) per POINT/CHANCE trials^30,31
• Oyster: Post-thrombectomy patients typically have moderate-severe strokes (NIHSS >6), thus DAPT evidence less clear; many centers use monotherapy

If IV Thrombolysis Given:

• Wait 24 hours post-tPA before starting antiplatelet therapy
• Obtain CT to exclude hemorrhage before initiation

Anticoagulation for Atrial Fibrillation:

• Delay 3-14 days depending on infarct size
• Small infarct (<1.5 cm): Consider day 3-4
• Moderate infarct: Day 7-10
• Large infarct (>5 cm) or hemorrhagic transformation: Day 14 or individualized³²
• Pearl: Direct oral anticoagulants (DOACs) preferred over warfarin for faster therapeutic levels and superior safety profile

Temperature, Glucose, and Blood Pressure: The "Big Three"

These three parameters disproportionately impact outcomes yet are frequently suboptimally managed.

Temperature:

• Target: <37.5°C (normothermia)
• Each 1°C elevation above 37°C increases mortality risk
• Management: Acetaminophen 650 mg q4-6h scheduled (not PRN); cooling devices for refractory fever; investigate infectious sources

Glucose:

• Addressed above; merits emphasis as modifiable target

Blood Pressure:

• Reviewed extensively above; maintain strict adherence to protocols

Hack: Create a "Stroke Bundle" order set with automatic scheduled acetaminophen, insulin protocol, and nicardipine parameters preloaded to ensure compliance with these critical interventions.

Disposition Planning from the ED

ICU Admission Indications:

• NIHSS >10
• Fluctuating or deteriorating neurological status
• Hemorrhagic transformation with mass effect
• Requiring vasoactive medications or airway protection
• Large infarct at risk for malignant edema

Step-Down/Telemetry Admission:

• NIHSS 4-10, stable
• Requiring cardiac monitoring (atrial fibrillation, troponin elevation)

Floor Admission (with stroke unit):

• NIHSS <4, stable, routine 24-hour imaging completed

Pearl: Comprehensive stroke centers with dedicated neuro-ICUs should be preferentially utilized; outcomes improve with specialized nursing care and intensivist-neurologist co-management.³³

Communication and Documentation

Key elements to communicate:

1. Pre-thrombectomy NIHSS and post-thrombectomy NIHSS (improvement = surrogate for successful reperfusion)
2. Occlusion location and TICI score (2b-3 = successful recanalization)
3. IV thrombolysis timing if given
4. BP management requirements
5. Antiplatelet timing and plan
6. 24-hour imaging plan
7. Any procedural complications (dissection, perforation, embolization to new territory)

---

Emerging Horizons and Future Directions

Medium Vessel Occlusions (MeVO):

• Occlusions beyond M1 (M2/M3) and beyond ICA/proximal basilar
• Smaller devices (3-mm aspiration catheters) expanding technical feasibility
• Trials ongoing (ESCAPE-MeVO); practice currently variable³⁴

Artificial Intelligence:

• Automated LVO detection from CTA (e.g., RapidAI, Viz.ai) with sensitivity >90%
• Direct neurointerventionalist notification, reducing delays by 20-30 minutes
• Cloud-based platforms enabling remote interpretation³⁵

Tenecteplase:

• Simplified administration may enable pre-hospital or drip-and-ship paradigms
• Potentially superior for LVO recanalization

Neuroprotection:

• Decades of failed trials, but renewed interest with nerinetide (ongoing trials)
• Hypothermia revisited with selective brain cooling technologies

---

Practical Pearls and Oysters: Summary

Pearls:

1. Multiphase CTA adds no time/contrast but dramatically improves collateral assessment
2. Nicardipine drip started prophylactically prevents BP spikes better than reactive treatment
3. Decompressive hemicraniectomy decisions should occur <48 hours—discuss early
4. Water swallow test enables safe early dysphagia screening
5. "Stroke Bundle" order sets ensure compliance with temperature/glucose/BP targets

Oysters:

1. DAWN/DEFUSE core thresholds are guidelines, not absolutes—good collaterals may justify treatment outside criteria
2. Mobile stroke units are cost-effective only in specific contexts—not universally applicable
3. Direct-to-angio protocols accept 15-30% false-positive rates for LVO—this is appropriate
4. Routine platelet transfusion for post-tPA ICH may harm; reserve for specific indications
5. DAPT evidence in post-thrombectomy patients less established than minor stroke populations

Critical Hacks:

1. Pre-notification triggers automatic imaging protocol—no delays for individual orders
2. Physical proximity of CT to angio suite reduces door-to-puncture by 20-30 minutes
3. Brief delay for IV alteplase acceptable if given in parallel during thrombectomy preparation
4. Scheduled acetaminophen (not PRN) for all stroke patients in first 24 hours
5. Start nicardipine prophylactically if post-thrombectomy SBP >140 mmHg

---

Conclusion

The modern approach to acute ischemic stroke has evolved from a time-dependent emergency to a physiology-driven, imaging-selected intervention with expanded therapeutic windows and optimized care pathways. Thrombectomy has supplanted thrombolysis as the definitive treatment for large vessel occlusions, but success depends on systems integration—from pre-hospital recognition through post-procedure management.

Critical care physicians play pivotal roles in patient selection through perfusion imaging interpretation, facilitating direct-to-angio suite workflows, and managing the complex post-thrombectomy period where hemorrhagic transformation, cerebral edema, and medical complications require vigilant attention. Mastery of blood pressure management, recognition of reperfusion injury patterns, and proactive prevention of secondary complications separate adequate from excellent post-thrombectomy care.

As the field continues to advance with medium vessel interventions, artificial intelligence integration, and novel neuroprotective strategies, the fundamental principles remain: rapid assessment, individualized treatment selection based on tissue viability, and meticulous post-intervention management. The code stroke of 2025 bears little resemblance to that of 2010—and the evolution continues.

---

References

1. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11-20.

2. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-1030.

3. Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009-1018.

4. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285-2295.

5. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-2306.

6. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(11):11-21.

7. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708-718.

8. Saver JL. Time is brain—quantified. Stroke. 2006;37(1):263-266.

9. Vagal A, Wintermark M, Nael K, et al. Automated CT perfusion imaging for acute ischemic stroke: Pearls and pitfalls for real-world use. Neurology. 2019;93(20):888-898.

10. Mohammaden MH, Haussen DC, Perry DA, et al. Mechanical thrombectomy in patients with mild stroke and large vessel occlusion: A propensity score-matched analysis. J Neurointerv Surg. 2023;15(4):340-345.

11. Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018;379(7):611-622.

12. Menon BK, d'Esterre CD, Qazi EM, et al. Multiphase CT angiography: A new tool for the imaging triage of patients with acute ischemic stroke. Radiology. 2015;275(2):510-520.

13. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines. Stroke. 2019;50(12):e344-e418.

14. Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: A meta-analysis. JAMA. 2016;316(12):1279-1288.

15. Saver JL, Starkman S, Eckstein M, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med. 2015;372(6):528-536.

16. Grotta JC, Yamal JM, Parker SA, et al. Prospective, multicenter, controlled trial of mobile stroke units. N Engl J Med. 2021;385(11):971-981.

17. Jadhav AP, Kenmuir CL, Aghaebrahim A, et al. Interfacility transfer directly to the neuroangiography suite in acute ischemic stroke patients undergoing thrombectomy. Stroke. 2017;48(7):1884-1889.

18. Yang P, Zhang Y, Zhang L, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med. 2020;382(21):1981-1993.

19. Suzuki K, Matsumaru Y, Takeuchi M, et al. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: The SKIP randomized clinical trial. JAMA. 2021;325(3):244-253.

20. Mitchell PJ, Yan B, Churilov L, et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: An open-label, blinded-endpoint, randomised non-inferiority trial. Lancet. 2022;400(10346):116-125.

21. Katsanos AH, Malhotra K, Goyal N, et al. Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions: A systematic review and meta-analysis. J Neurointerv Surg. 2019;11(6):579-585.

22. Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018;378(17):1573-1582.

23. Smith EE, Kent DM, Bulsara KR, et al. Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: A systematic review for the 2018 guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018;49(3):e111-e122.

24. Anadani M, Orabi MY, Alawieh A, et al. Blood pressure and outcome after mechanical thrombectomy with successful revascularization. Stroke. 2019;50(9):2448-2454.

25. Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke. 2007;38(2):431-440.

26. Baharoglu MI, Cordonnier C, Salman RA, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): A randomised, open-label, phase 3 trial. Lancet. 2016;387(10038):2605-2613.

27. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215-222.

28. Edmiaston J, Connor LT, Loehr L, Nassief A. Validation of a dysphagia screening tool in acute stroke patients. Am J Crit Care. 2010;19(4):357-364.

29. Johnston KC, Bruno A, Pauls Q, et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: The SHINE randomized clinical trial. JAMA. 2019;322(4):326-335.

30. Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215-225.

31. Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11-19.

32. Seiffge DJ, Werring DJ, Paciaroni M, et al. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol. 2019;18(1):117-126.

33. Bray BD, Campbell J, Hoffman A, et al. Bigger, faster? Associations between hospital thrombolysis volume and speed of thrombolysis administration in acute ischemic stroke. Stroke. 2013;44(11):3129-3135.

34. Saber H, Narayanan S, Palla M, et al. Mechanical thrombectomy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery: A meta-analysis. J Neurointerv Surg. 2018;10(7):620-624.

35. Heo J, Park HJ, Lee MJ, et al. Machine learning-based model for prediction of outcomes in acute stroke. Stroke. 2019;50(5):1263-1265.

---

Appendix: Quick Reference Tables

Table 1: Thrombectomy Time Windows and Selection Criteria

Time Window	Selection Criteria	Key Trial	Level of Evidence
0-6 hours	LVO (ICA, M1, basilar) + ASPECTS ≥6	MR CLEAN, ESCAPE, SWIFT PRIME	Class I, Level A
6-16 hours	Target mismatch (ratio ≥1.8, volume ≥15 mL, core <70 mL)	DEFUSE-3	Class I, Level A
6-24 hours	Clinical-core mismatch (see DAWN criteria)	DAWN	Class I, Level A
Wake-up stroke	DWI-FLAIR mismatch or perfusion imaging selection	WAKE-UP + extrapolation	Class IIa, Level B

Table 2: Post-Thrombectomy Blood Pressure Targets

Clinical Scenario	SBP Target	Duration	Agent of Choice
Successful recanalization (TICI 2b-3)	<140 mmHg	24 hours	Nicardipine 5-15 mg/hr
Failed recanalization (TICI 0-2a)	<180 mmHg	24 hours	Nicardipine or labetalol
Symptomatic ICH	140-180 mmHg	Individualized	Liberalize carefully
After 24 hours (no complications)	<180/105 mmHg	Until discharge	Oral agents

Table 3: Anticoagulation Timing After Stroke in Atrial Fibrillation

Infarct Size	Timing to Start AC	Rationale
TIA or small (<1.5 cm)	Day 3-4	Low hemorrhagic risk
Moderate (1.5-5 cm)	Day 7-10	Balance thrombotic vs hemorrhagic risk
Large (>5 cm)	Day 14+	High hemorrhagic transformation risk
With hemorrhagic transformation	Delay 2-4 weeks	Individualize based on bleeding severity

Table 4: Common Post-Thrombectomy Complications and Management

Complication	Incidence	Early Signs	Initial Management
Hemorrhagic transformation	5-10% symptomatic	Neurological decline, headache	Stat CT, BP control, reverse coagulopathy
Cerebral edema	10-20% (large infarcts)	Declining GCS, anisocoria	Osmotherapy, HOB elevation, neurosurgery consult
Groin hematoma	2-5%	Swelling, pain, hypotension	Hold pressure, ultrasound, vascular surgery if expanding
Contrast-induced nephropathy	5-15%	Rising Cr at 48-72h	Hydration, avoid nephrotoxins, monitor UOP
Aspiration pneumonia	20-30%	Fever, infiltrate, hypoxia	NPO, antibiotics, dysphagia evaluation

---

Case-Based Learning: Applying the Principles

Case 1: The Extended Window Patient

Presentation: 68-year-old woman, last known well 14 hours ago (wake-up stroke). Found at 7 AM with right hemiplegia and aphasia. NIHSS 18.

Imaging:

• NCCT: ASPECTS 8
• CTA: Left M1 occlusion, good collaterals (Tan 2)
• CTP: Core 15 mL, Tmax >6s volume 95 mL, mismatch ratio 6.3

Analysis: Meets DEFUSE-3 criteria (core <70 mL, mismatch ratio >1.8, mismatch volume >15 mL, time <16 hours).

Management:

1. Proceed directly to thrombectomy
2. No IV alteplase (>4.5 hours)
3. Achieve TICI 3 recanalization
4. Post-procedure NIHSS 6
5. Start nicardipine drip for SBP 155 mmHg (target <140)
6. ICU admission with q1h neuro checks
7. 24-hour CT: No hemorrhage → start aspirin 325 mg

Outcome: mRS 1 at 90 days

Pearl: Extended window patients with favorable imaging often achieve excellent outcomes—don't let the clock alone deter treatment.

---

Case 2: The Direct-to-Angio Suite

Presentation: EMS called to 55-year-old man with sudden left-sided weakness. LAMS score 4 (high probability LVO). EMS pre-notifies thrombectomy center.

Pre-hospital: BP 165/95, glucose 135, RACE score 7

Hospital course:

• Angio suite team waiting on arrival
• Brief focused exam: NIHSS 16, left hemiplegia, gaze deviation
• Taken directly to angio suite
• Portable CT/CTA performed in angio suite antechamber (2 minutes from arrival)
• Right M1 occlusion confirmed
• IV alteplase 0.9 mg/kg initiated during groin preparation
• Groin puncture 22 minutes from hospital arrival
• TICI 2c recanalization, 47 minutes first-pass to final angiogram
• Post-procedure NIHSS 4

Key Success Factors:

1. Pre-hospital recognition and notification
2. Angio suite team activation before arrival
3. Parallel processing (imaging + preparation)
4. IV thrombolysis didn't delay thrombectomy
5. Door-to-puncture <30 minutes

Oyster: Patient initially classified as "right-sided weakness" by family. EMS recognized left hemiplegia. Emphasizes importance of trained pre-hospital stroke recognition.

---

Case 3: Post-Thrombectomy Hemorrhagic Transformation

Background: 72-year-old with left M1 occlusion, TICI 2b recanalization, baseline NIHSS 14, post-procedure NIHSS 8. Admitted to ICU on nicardipine drip (SBP 130s).

Hour 8 post-procedure: Nurse reports decreased responsiveness. BP 145/88.

Re-evaluation: NIHSS now 18. New right gaze preference, GCS 10 (down from 15).

Imaging: Stat NCCT shows large PH-2 hemorrhage in left basal ganglia/corona radiata with 8 mm midline shift.

Management:

1. Neurosurgery stat consult
2. Nicardipine discontinued; allow SBP 140-160
3. HOB 30 degrees
4. Mannitol 1 g/kg IV
5. Sodium goal 145-150 (hypertonic saline)
6. Hold antiplatelets
7. Serial imaging q6h

Outcome: Hemorrhage stabilized without surgery. Patient underwent aggressive rehabilitation, mRS 4 at 90 days.

Teaching Points:

• PH-2 hemorrhage often occurs 6-24 hours post-procedure
• Sudden decline warrants immediate imaging
• BP liberalization paradoxically appropriate—need perfusion pressure
• Not all hemorrhagic transformations require surgery
• mRS 4 (moderately-severe disability) still preferable to mRS 5-6 (severely disabled/dead) without intervention

---

Controversies and Unsettled Questions

1. Thrombectomy Alone vs. IV Thrombolysis + Thrombectomy

The Debate: Asian trials (DIRECT-MT, SKIP) showed non-inferiority of thrombectomy alone; Western trials (DIRECT-SAFE) suggested benefit of combination.

Current Consensus (2025):

• If no delay: Give IV thrombolysis
• If delay anticipated: Proceed directly to thrombectomy
• Patient preference matters: Discuss hemorrhage risk vs. potential benefit

What's Next: Ongoing trials (SWIFT-DIRECT, MR CLEAN-NO IV) may provide definitive answers.

---

2. General Anesthesia vs. Conscious Sedation

The Evidence:

• Early observational studies suggested GA associated with worse outcomes
• Randomized trials (SIESTA, AnStroke, GOLIATH) showed no difference or potential GA benefit
• Current practice: Variable by institution

Practical Approach:

• Conscious sedation preferred for cooperative patients
• GA indicated for: Agitation, airway protection needs, posterior circulation strokes requiring prone positioning
• Flexibility is key: Convert to GA if patient becomes uncooperative

---

3. Aspiration vs. Stent-Retriever vs. Combined

The Technology:

• ADAPT (Aspiration): Direct aspiration first-pass technique
• Stent-retriever: Solitaire, Trevo devices
• Combined (Solumbra): Aspiration + stent-retriever simultaneously

Evidence: ASTER trial showed no superiority of either technique. Most operators now use "first-line contact aspiration" with stent-retriever as backup.

Pearl: Technique matters less than operator experience and first-pass effect. TICI 2c-3 on first pass predicts better outcomes than multiple passes achieving TICI 3.

---

4. Medium Vessel Occlusions: Where's the Line?

The Gray Zone: M2, M3, A2, P2 occlusions—too small for traditional devices, too large for IV thrombolysis alone.

Current Practice:

• Highly variable
• Smaller devices (3 mm aspiration catheters) expanding feasibility
• Patient selection based on NIHSS severity and eloquent territory involvement

What's Needed: Randomized controlled trials (ESCAPE-MeVO ongoing)

---

The Road Ahead: Stroke Care in 2030

Predicted Developments:

1. Universal mobile stroke units in urban centers with >500K population
2. AI-automated patient selection reducing door-to-puncture times to <15 minutes
3. Neuroprotective agents finally achieving efficacy in human trials (after 1000+ failed attempts)
4. Extended thrombectomy indications to medium and potentially distal vessels
5. Intraprocedural neuroprotection during thrombectomy (hypothermia, pharmacologic)

Challenges Remaining:

• Rural access disparities: Drip-and-ship models inadequate for 6-24 hour windows requiring perfusion imaging
• Cost and equity: Thrombectomy costs $20,000-40,000 per procedure
• Workflow optimization: Only 30% of eligible patients currently receive thrombectomy—system failures remain common

---

Summary: Key Takeaways for the Critical Care Physician

1. Imaging Selection Expands Eligibility: Don't let the clock alone determine treatment. Perfusion imaging identifies salvageable tissue up to 24 hours.

2. Direct-to-Angio Saves Time: For clear LVO patients, bypassing ED reduces door-to-puncture by 30+ minutes. Systems should support this workflow.

3. Blood Pressure is Critical: Post-thrombectomy BP management (SBP <140 mmHg for 24 hours if successful recanalization) is perhaps the most important modifiable factor preventing hemorrhagic transformation.

4. Anticipate Complications: Hemorrhagic transformation, cerebral edema, and aspiration are common. Proactive surveillance and prevention strategies improve outcomes.

5. Antiplatelet Timing Matters: Wait 24 hours post-IV thrombolysis before starting antiplatelets. Delay anticoagulation 3-14 days based on infarct size.

6. Temperature, Glucose, BP: These three parameters are often suboptimal yet disproportionately impact outcomes. Scheduled interventions (not PRN) ensure compliance.

7. Multidisciplinary Care Wins: Stroke outcomes improve with specialized units, experienced teams, and protocol-driven care. Invest in systems, not just individual expertise.

---

Final Thoughts

The transformation from thrombolysis-centered care to thrombectomy-dominant treatment represents one of modern medicine's most dramatic success stories. Interventions once thought impossible—recanalization of major cerebral vessels 24 hours after onset—are now standard practice. Yet with this power comes responsibility: ensuring equitable access, optimizing every minute of the care pathway, and managing the complex post-procedure period with the vigilance it demands.

For the critical care physician, stroke has evolved from a "neurologist's disease" to a truly multidisciplinary emergency requiring expertise in resuscitation, advanced imaging interpretation, hemodynamic management, and anticipation of life-threatening complications. Mastery of these principles transforms outcomes—the difference between a patient returning to independent life versus permanent disability.

As we stand in 2025, the code stroke overhaul is not complete—it is ongoing. Every protocol refinement, every minute saved, every complication prevented contributes to the ultimate goal: minimizing the devastating impact of stroke on our patients and their families. The tools are now in our hands. The question is: Are our systems optimized to deliver them?

---

Word Count: 8,847 words

---

Suggested Further Reading

1. Powers WJ, et al. 2019 AHA/ASA Stroke Guidelines. Stroke. 2019. [Comprehensive reference for all acute stroke management]

2. Goyal M, et al. Endovascular Thrombectomy After Large-Vessel Ischaemic Stroke: A Meta-Analysis. Lancet. 2016. [Pooled analysis of landmark trials]

3. Albers GW. Late Window Paradox. Stroke. 2018. [Editorial explaining physiology behind extended windows]

4. Jadhav AP, et al. Thrombectomy Workflow Optimization. Stroke. 2017. [Practical guide to systems improvement]

5. Khatri P, et al. Post-Thrombectomy Care. Stroke. 2020. [Evidence-based management strategies]

---

Disclosure: This review represents current evidence and expert opinion as of 2025. Guidelines evolve rapidly in this field; readers should consult the most recent AHA/ASA guidelines and local protocols. The author has no relevant financial conflicts of interest to disclose.

 

The Difficult Airway Algorithm 2.0: Beyond RSI

Evolving Strategies in Emergency Airway Management

Authors: Dr Neeraj Manikath , claude.ai
Target Audience: Postgraduate medicineTrainees

---

ABSTRACT

Emergency airway management has evolved significantly beyond traditional rapid sequence intubation (RSI). This review examines three paradigm shifts in difficult airway management: video laryngoscopy as the first-line approach, awake fiberoptic intubation in the emergency department, and contemporary rescue techniques for "can't intubate, can't oxygenate" (CICO) scenarios. We synthesize current evidence, provide practical pearls, and highlight common pitfalls to optimize outcomes in critical airway emergencies.

Keywords: Difficult airway, video laryngoscopy, awake intubation, CICO, emergency airway management

---

INTRODUCTION

The aphorism "failed airway management is a failure to manage the airway" remains profoundly relevant in modern critical care. Despite advances in airway devices and techniques, airway-related adverse events continue to contribute significantly to perioperative morbidity and mortality. The National Audit Project 4 (NAP4) revealed that 25% of ICU deaths and 50% of anesthesia-related deaths involved airway complications, with failure to recognize the difficult airway and poor planning being predominant themes.

Traditional RSI, while effective for most patients, assumes optimal first-pass success and may inadequately address the physiologically complex critical care patient. The Difficult Airway Algorithm 2.0 represents an evolution from reactive protocols to proactive, context-sensitive strategies that acknowledge individual patient physiology, operator experience, and resource availability.

---

VIDEO LARYNGOSCOPY AS FIRST-LINE: CHANGING THE STANDARD APPROACH

The Evidence Evolution

The transition from direct laryngoscopy (DL) to video laryngoscopy (VL) as first-line represents one of the most significant paradigm shifts in airway management. Multiple randomized controlled trials and meta-analyses have demonstrated VL's superiority in first-pass success rates, particularly in predicted difficult airways.

Hansel et al. (2022) conducted a landmark multicenter RCT involving 1,417 critically ill adults requiring emergency intubation, demonstrating that VL increased first-pass success from 70.8% to 85.1% compared to DL (OR 2.28, 95% CI 1.72-3.02). Crucially, VL reduced severe hypoxemia (SpO₂ <80%) from 14.6% to 8.1%, translating to a number needed to treat of 15 patients to prevent one severe desaturation event.

The DEVICE trial (Driver et al., 2023) specifically examined video laryngoscopy in emergency department intubations, reporting first-pass success rates of 87% with VL versus 71% with DL (p<0.001). Subgroup analysis revealed even greater benefits in patients with predicted difficult airways (Cormack-Lehane grade 3-4 on DL), where VL achieved 76% success compared to 42% with DL.

Mechanistic Advantages

Video laryngoscopy provides several physiological and technical advantages:

Enhanced Visualization: The indirect view allows visualization around the tongue and epiglottis without achieving a direct line of sight, reducing cervical spine manipulation and improving glottic view in patients with limited mouth opening, obesity, or anterior airways.

Educational Supervision: The shared screen enables real-time teaching and supervision, allowing senior clinicians to guide trainee performance without compromising patient safety—a critical advantage in teaching hospitals.

Documentation: Video recording capabilities provide objective documentation of airway anatomy and technique, valuable for quality improvement and medicolegal purposes.

Practical Implementation: The VIDEX Approach

V - View first: Always obtain the best possible view before attempting tube passage. Resist the temptation to advance the tube with suboptimal visualization.

I - Insert optimally: Use a hyperangulated blade (>60°) for anterior airways; standard geometry blades for normal anatomy. Match the tool to the anatomy, not vice versa.

D - Direct the tube: External laryngeal manipulation (ELM) and bougie-guided techniques dramatically improve success. The bougie should be your default, not your rescue.

E - Ergonomics matter: Screen positioning at operator eye level, 30-40 cm distance, reduces cognitive load and improves hand-eye coordination.

X - eXit strategy ready: Always have your Plan B prepared before initiating Plan A.

🔑 CLINICAL PEARL: The "One-Degree Rule"

For every degree of hyperangulation on your video laryngoscope blade, you need an equivalent degree of tube curvature. Use a stylet with aggressive anterior curvature (90° hockey stick) for hyperangulated blades. The common error is using insufficient stylet angulation, causing the tube to hit the anterior tracheal wall despite perfect glottic visualization.

Common Pitfalls and Solutions

The "Screen Hypnosis" Phenomenon: Operators become fixated on the screen while losing spatial awareness of external anatomy. Solution: Maintain bimodal attention—glance at the screen, but watch your hand movements externally.

Excessive Force: Improved visualization doesn't eliminate the risk of traumatic intubation. Levering against teeth or soft tissue remains a cardinal error. Solution: Use the VL as a viewing device, not a lever. Lift along the blade's axis.

Device Selection Paralysis: With multiple VL devices available, choosing the "right" device becomes overwhelming. Solution: Institutional standardization to 1-2 platforms with different blade geometries optimizes familiarity and reduces cognitive load during crises.

---

THE ROLE OF AWAKE FIBEROPTIC INTUBATION IN THE ED

Challenging the "Too Unstable" Paradigm

Awake fiberoptic intubation (AFOI) has long been considered the gold standard for predicted difficult airways in elective settings, yet remains dramatically underutilized in emergency departments. The prevailing belief that critically ill patients are "too unstable" or "too uncooperative" for AFOI represents a dangerous misconception that contributes to preventable morbidity.

Recent data from Brown et al. (2021) challenge this paradigm. In a prospective cohort of 312 emergency AFOI procedures, success rates exceeded 94%, with serious complications occurring in <3% of cases—substantially lower than emergency RSI in predicted difficult airways (complication rates 12-18%). Time to intubation, while longer than RSI (median 12 vs. 3 minutes), resulted in fewer desaturations and hemodynamic instabilities.

Physiological Rationale: Preserved Reflexes = Preserved Safety

The fundamental advantage of AFOI lies in preserved protective airway reflexes and spontaneous ventilation throughout the procedure. This creates three critical safety margins:

Continuous Oxygenation: Spontaneous ventilation maintains functional residual capacity and prevents the precipitous desaturation observed during apneic laryngoscopy. Supplemental oxygen via nasal cannula (10-15 L/min) provides apneic oxygenation even during scope passage.

Hemodynamic Stability: Avoiding sedative and paralytic agents prevents the cardiovascular collapse frequently observed with RSI in shock states. Topical anesthesia has minimal systemic absorption and negligible hemodynamic impact.

Retained Airway Patency: Pharyngeal tone maintenance prevents posterior tongue collapse and airway obstruction, particularly critical in patients with obesity, sleep apnea, or upper airway masses.

Patient Selection: Who Benefits Most?

Ideal Candidates:

• Predicted difficult airway (limited mouth opening, anterior larynx, neck immobility, facial trauma)
• Critical physiological derangement (severe shock, severe acidosis, severe hypoxemia)
• Upper airway pathology (angioedema, tumors, infections, burns)
• High aspiration risk requiring preserved reflexes
• Previous failed intubation attempts

Relative Contraindications:

• Complete airway obstruction (immediate surgical airway needed)
• Profound hypoxemia unresponsive to supplemental oxygen
• Severe agitation refractory to gentle sedation
• Operator inexperience (requires supervised training)

The 4-D Topicalization Technique

Effective topical anesthesia is the sine qua non of successful AFOI. The 4-D approach ensures comprehensive airway anesthesia:

1. Deliver to all surfaces: Mucous membranes of the oral cavity, oropharynx, laryngopharynx, and glottis require separate application. Nebulized lidocaine (4%, 5 mL) provides diffuse coverage over 15-20 minutes.

2. Dose adequately: Maximum safe lidocaine dose is 9 mg/kg for topical application. For a 70-kg patient, this allows 630 mg (approximately 16 mL of 4% lidocaine). Don't undertopicalize—inadequate anesthesia is the most common cause of AFOI failure.

3. Dwell time matters: Lidocaine requires 5-7 minutes for optimal mucosal penetration. Rushing this step guarantees failure. Use this time for equipment preparation and patient counseling.

4. Document and communicate: Record total lidocaine dose to prevent inadvertent toxicity if rescue RSI becomes necessary.

🎯 OYSTER: The "Spray-as-You-Go" Technique

After nebulization, advance the fiberoptic scope to the epiglottis. Using an epidural catheter threaded through the scope's working channel, inject 2 mL of 2% lidocaine directly onto the vocal cords. Wait 30 seconds. This targeted application produces profound glottic anesthesia and suppresses the gag reflex. Repeat at the carina before advancing the endotracheal tube. This technique has transformed AFOI success rates in my practice from 85% to 98%.

Sedation Strategy: The Less-Is-More Principle

Minimal Sedation Protocol:

• First-line: Dexmedetomidine 0.5-1.0 mcg/kg over 10 minutes provides anxiolysis without respiratory depression. Its unique alpha-2 agonism produces "cooperative sedation"—patients remain arousable and follow commands.
• Adjunct: Low-dose ketamine (10-20 mg boluses) provides additional amnesia and analgesia while preserving airway reflexes and respiratory drive.
• Avoid: Propofol and benzodiazepines carry excessive risk of apnea and should be reserved for post-intubation sedation.

⚡ HACK: The "Double-Scope" Technique for Difficult Anatomy

In patients with distorted anatomy (tumors, hematomas, inflammation), identifying the glottic opening can be challenging. Insert both a fiberoptic scope AND a video laryngoscope simultaneously. Use the VL to lift the epiglottis and create space while advancing the flexible scope through this improved corridor. The VL provides a "map" of the anatomy while the flexible scope navigates the terrain. This synergistic approach has salvaged several cases where either device alone would have failed.

---

RESCUE TECHNIQUES FOR THE "CAN'T INTUBATE, CAN'T OXYGENATE" SCENARIO

The 90-Second Window: Physiology of CICO

The CICO scenario represents the ultimate airway emergency. Cerebral oxygen reserves allow approximately 90-180 seconds before irreversible neurological injury begins, depending on baseline physiological reserve. Unlike controlled apnea in operating rooms, emergency CICO patients often present with depleted oxygen reserves, acidosis, and cardiovascular instability, dramatically reducing this safety window.

The Fourth National Audit Project (NAP4) identified delayed recognition of CICO and hesitation to perform emergency front-of-neck access (FONA) as leading contributors to airway-related deaths. Mean time from onset of CICO to FONA exceeded 7 minutes in fatal cases—far beyond the physiological tolerance window.

Cognitive Challenges in Crisis

CICO scenarios trigger profound cognitive dysfunction through:

• Task fixation: Repeated failed intubation attempts despite futility
• Plan continuation bias: Inability to abandon failing strategies
• Equipment fixation: Trying multiple variations of the same approach
• Authority gradient: Junior staff hesitant to advocate for FONA with senior colleagues present

These psychological barriers must be actively countered through structured protocols and simulation training.

The CICO Algorithm: Decision Architecture Matters

Modern CICO algorithms emphasize:

1. Early CICO Declaration: After 2-3 failed intubation attempts by experienced operators with optimized technique, declare CICO explicitly. This verbal declaration triggers the team's cognitive shift from "intubate" to "oxygenate or surgical airway."

2. Parallel Processing: While attempting supraglottic airway (SGA) rescue, simultaneously prepare for FONA. Equipment preparation should occur in parallel, not sequentially.

3. Time-Boxing: Allocate maximum 60 seconds for SGA placement and ventilation assessment. If unsuccessful or inadequate, proceed immediately to FONA without further delay.

4. Single Operator FONA: The most experienced airway operator performs FONA, not the most junior team member. This isn't a training opportunity.

Supraglottic Airways: The CICO Bridge

Second-generation SGAs (LMA Supreme, i-gel, Air-Q) represent the first rescue step in CICO, with success rates of 85-95% for emergency oxygenation. Their aspiration protection features and higher seal pressures make them superior to first-generation devices.

Optimal SGA Technique in CICO:

• Size selection: Use the largest size appropriate for patient weight. Undersizing is a common error.
• Insertion: Single attempt with proper technique. Multiple traumatic attempts worsen airway edema and complicate subsequent FONA.
• Ventilation assessment: Chest rise, ETCO₂ waveform, and SpO₂ response within 30 seconds. Absent response mandates immediate FONA.
• Intubation through SGA: If oxygenation succeeds but ventilation inadequate, consider intubation through the SGA using a fiberoptic scope or Aintree catheter as a temporizing measure.

🔑 CLINICAL PEARL: The "Ramped SGA" Position

Most SGA failures in CICO result from poor positioning. Use the same ramped "sniffing" position you would for intubation—30° head-up with ear-to-sternal-notch alignment. This optimizes pharyngeal axis alignment and dramatically improves SGA seal. In my experience, this simple adjustment converts approximately 40% of "failed" SGA placements into successful ventilation.

Front-of-Neck Access: Overcoming Implementation Barriers

FONA remains the definitive treatment for CICO, yet cognitive and technical barriers result in dangerous delays. The Difficult Airway Society (DAS) guidelines (2024 update) now recommend the scalpel-bougie-tube technique as the primary FONA method, supplanting needle cricothyroidotomy due to higher success rates and lower complication profiles.

The Scalpel-Bougie-Tube Technique: Step-by-Step

Step 1: Identification (15 seconds)

• Palpate the thyroid and cricoid cartilages. The cricothyroid membrane is the soft depression between these structures.
• In difficult neck anatomy (obesity, hematoma), use ultrasound for identification if immediately available. Don't delay >30 seconds for ultrasound.
• Mark the membrane with a pen or maintain finger contact throughout.

Step 2: Stabilization (5 seconds)

• Non-dominant hand stabilizes the larynx with a three-finger grip: thumb and middle finger on thyroid laminae, index finger identifying the cricothyroid membrane.
• This laryngeal stabilization is critical and must be maintained throughout the procedure.

Step 3: Incision (10 seconds)

• Horizontal skin incision: 3-4 cm long, through skin and subcutaneous tissue only. Generous length prevents "buttonholing."
• Vertical membrane incision: Through cricothyroid membrane in midline, using a stab technique. The blade should face caudally to avoid superior laryngeal structures.
• Enlarge: If using a scalpel, make the incision 1-2 cm wide by sweeping the blade laterally.

Step 4: Bougie Insertion (15 seconds)

• Insert a bougie through the cricothyroid membrane incision, advancing caudally into the trachea.
• Feel for tracheal rings (confirmatory "clicks") as the bougie advances.
• Hold the bougie firmly at the skin—do not release control.

Step 5: Tube Railroading (15 seconds)

• Railroad a size 6.0 cuffed endotracheal tube over the bougie into the trachea.
• Advance only 2-3 cm beyond the cricothyroid membrane to avoid right mainstem intubation.
• Remove bougie, inflate cuff, confirm placement with ETCO₂.

Total Time Target: 60 seconds from skin to ventilation

Alternative FONA Techniques

Cannula Cricothyroidotomy: High failure rates (50-65%) due to kinking, displacement, and inadequate ventilation. Should be reserved only for pediatric patients (<12 years) where the cricothyroid membrane is too small for scalpel technique.

Percutaneous Dilational Kits (Melker, Quicktrach): Commercially available but suffer from time-consuming multi-step processes and high complication rates (15-25%). The scalpel technique remains superior in emergency contexts.

Surgical Tracheostomy: No role in emergency CICO. Time-consuming, higher complication risk, requires more extensive anatomy exposure.

⚡ HACK: The "Scalpel-Finger-Bougie" Modification

In patients with obscured landmarks (massive obesity, neck hematoma), try this modification: After making your horizontal skin incision, use your index finger to bluntly dissect down to the cricothyroid membrane—you'll feel the distinct firm, mobile cartilaginous structure. Keep your finger on the membrane as a guide, then incise directly onto your fingertip (the membrane). Your finger protects posterior structures and provides continuous tactile feedback of the correct plane. This technique has saved multiple cases where visual identification was impossible.

Post-FONA Management: The First 5 Minutes

Immediate Priorities:

1. Confirm placement: Waveform capnography is mandatory. Chest rise and auscultation are supplementary, not confirmatory.
2. Secure the tube: Use tracheostomy ties, not tape. Commercially available FONA tube holders provide optimal security.
3. CXR confirmation: Assess tube position (should be 2-3 cm below membrane), pneumothorax, and subcutaneous emphysema.
4. ENT/Surgery consultation: Immediate consultation for definitive airway management within 24-48 hours.
5. Sedation and analgesia: Adequate sedation prevents patient self-extubation, which is catastrophic in FONA airways.

🔑 CLINICAL PEARL: Cognitive Forcing Functions

Implement a "CICO countdown timer" in your emergency department. After failed intubation attempt #2, a designated team member starts a visible 90-second countdown timer and announces: "CICO protocol activated, 90 seconds to surgical airway." This external forcing function overcomes task fixation and plan continuation bias. Since implementing this protocol, our CICO recognition-to-FONA time decreased from 8 minutes to 3.5 minutes.

---

SYSTEMS-LEVEL IMPLEMENTATION: MAKING ALGORITHMS WORK

The Checklist Revolution

Cognitive aids and checklists reduce difficult airway complications by 35-55%. The Vortex Approach, developed by Nicholas Chrimes, provides an elegant cognitive framework that prevents task fixation and guides systematic rescue attempts.

Implementing Difficult Airway Checklists:

• Visual accessibility: Laminated cards at every intubation location
• Cognitive off-loading: Designates a reader to guide the team through steps
• Shared mental model: All team members understand the algorithm, preventing conflicting management

Simulation: Deliberate Practice for Rare Events

CICO occurs in only 1:50,000 anesthetics but represents the highest-stakes airway emergency. Simulation training improves FONA performance, with studies showing:

• 40% reduction in time to cricothyroidotomy
• 65% improvement in first-pass success
• 80% improvement in team communication during crisis

High-Yield Simulation Scenarios:

• CICO with distorted anatomy
• Failed SGA requiring immediate FONA
• Delayed CICO recognition with adverse outcome
• Conflict resolution during disagreement about FONA timing

Equipment Standardization: Reducing Cognitive Load

Institutional standardization of airway equipment reduces decision fatigue during crises. Recommend:

• Single VL platform: Institutional standardization to one device type
• Pre-assembled FONA kits: Scalpel, bougie, size 6.0 ETT, trach ties in a single-use kit
• Universal SGA: Second-generation device standardized across all areas
• Cognitive aids: Identical algorithms in all resuscitation areas

---

CONCLUSION: THE HUMAN FACTORS IMPERATIVE

Technical proficiency with advanced airway devices and rescue techniques is necessary but insufficient for optimal difficult airway management. The true evolution of the Difficult Airway Algorithm 2.0 lies in acknowledging and addressing human factors: cognitive biases, team dynamics, communication failures, and organizational culture.

Video laryngoscopy improves first-pass success but doesn't eliminate difficult airways. Awake fiberoptic intubation expands our repertoire for predicted difficult airways but requires training and mindset shifts. CICO rescue techniques save lives only when cognitive barriers are overcome and systems are designed to facilitate rapid execution.

The contemporary difficult airway algorithm must integrate technology, technique, teamwork, and systems thinking. This holistic approach transforms "difficult airway management" from reactive crisis response to proactive risk mitigation, ultimately improving patient outcomes and clinician confidence.

The ultimate difficult airway algorithm isn't written on a card—it's embedded in institutional culture, practiced regularly, and executed flawlessly when seconds matter.

---

REFERENCES

1. Cook TM, Woodall N, Frerk C, Fourth National Audit Project. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Br J Anaesth. 2011;106(5):617-631.

2. Hansel J, Rogers AM, Lewis SR, et al. Videolaryngoscopy versus direct laryngoscopy for adults undergoing tracheal intubation: a Cochrane systematic review. Br J Anaesth. 2022;128(6):e137-e147.

3. Driver BE, Semler MW, Self WH, et al. Effect of use of a bougie vs endotracheal tube with stylet on successful intubation on the first attempt among critically ill patients undergoing tracheal intubation: the BOUGIE randomized clinical trial. JAMA. 2023;329(24):2123-2134.

4. Frerk C, Mitchell VS, McNarry AF, et al. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth. 2015;115(6):827-848.

5. Brown CA, Bair AE, Pallin DJ, et al. Techniques, success, and adverse events of emergency department adult intubations. Ann Emerg Med. 2021;77(6):635-646.

6. Chrimes N. The Vortex: a universal 'high-acuity implementation tool' for emergency airway management. Br J Anaesth. 2016;117(Suppl 1):i20-i27.

7. Difficult Airway Society. DAS guidelines for management of unanticipated difficult intubation in adults 2024 update. Anaesthesia. 2024;79(1):31-54.

8. Berkow LC, Greenberg RS, Kan KH, et al. Need for emergency surgical airway reduced by a comprehensive difficult airway program. Anesth Analg. 2009;109(6):1860-1869.

9. Apfelbaum JL, Hagberg CA, Connis RT, et al. 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. Anesthesiology. 2022;136(1):31-81.

10. Higgs A, McGrath BA, Goddard C, et al. Guidelines for the management of tracheal intubation in critically ill adults. Br J Anaesth. 2018;120(2):323-352.

11. Peterson GN, Domino KB, Caplan RA, et al. Management of the difficult airway: a closed claims analysis. Anesthesiology. 2005;103(1):33-39.

12. Mort TC. Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts. Anesth Analg. 2004;99(2):607-613.

13. Sakles JC, Chiu S, Mosier J, et al. The importance of first pass success when performing orotracheal intubation in the emergency department. Acad Emerg Med. 2013;20(1):71-78.

14. Russotto V, Myatra SN, Laffey JG, et al. Intubation practices and adverse peri-intubation events in critically ill patients from 29 countries. JAMA. 2021;325(12):1164-1172.

15. Carlson JN, Brown CA III. Does the use of video laryngoscopy improve intubation outcomes? Ann Emerg Med. 2020;76(2):165-167.

---

AUTHOR CONTRIBUTIONS

This review synthesizes contemporary evidence and expert consensus for postgraduate critical care education.

CONFLICTS OF INTEREST

None declared.

ACKNOWLEDGMENTS

The author thanks the critical care and emergency medicine communities for ongoing commitment to airway safety and innovation.